baber/WOPTO huggingface dataset:
Patent DE-69724519-T2 (DE)
Inventor: DUCCINI YVES
IPC: C11D17/06
Filed: 1997-06-10
Granted: 2004-07-08
Abstract: A detergent tablet is disclosed which comprises at least 50 wt% of a non-phosphate builder and from 0 to 20 wt% of a phosphate builder, and has incorporated therein as binder from 0.3 to 5 wt% of a neutralised polymer of hydrophilic or hydrophobic monomers which have a glass transition temperature (Tg) of from 40 to 120 DEG C, which monomers comprise(meth)acrylic acid, maleic anhydride, hydroxyalkyl(meth)acrylic acids, alkyl (meth)acrylates, alkylhydroxy (meth)acrylates, alkyl (meth)acrylic acids or styrene, the polymer having a weight average molecular weight of from 10,000 to 120,000. The tablet has improved physical properties compared with those of the prior art.
Patent DE-69731097-T2 (DE)
Inventor: TERLAU HEINRICH
IPC: C07K14/435
Filed: 1997-03-14
Granted: 2005-02-17
Abstract: A new peptide,  kappa -conotoxin PVIIA, is disclosed. This peptide is found naturally in the cone snail Conus purpurascens and has the amino acid sequence Cys-Arg-Ile-Xaa-Asn-Gln-Lys-Cys-Phe-Gln-His-Leu-Asp-Asp-Cys-Cys-Ser-Arg-Lys-Cys-Asn-Arg-Phe-Asn-Lys-Cys-Val (SEQ ID NO:1) where Xaa represents 4-trans-hydroxyproline hydroxyproline or proline. This peptide together with a previously disclosed peptide,  delta -conotoxin PVIA, act synergistically to rapidly immobilize fish which are injected with the two peptides. Injection of  kappa -conotoxin PVIIA alone results in different symptoms with an injected fish becoming hyperactive and then contracting and suddenly extending all major fins. This "fin-popping" occurs repeatedly resulting in a series of jerky movements, but injection of only  kappa -conotoxin PVIIA does not immobilize or kill the fish.
Patent DE-69733750-T2 (DE)
Inventor: BODICKY O
IPC: A61B17/34
Filed: 1997-03-19
Granted: 2006-01-05
Abstract: A gastrointestinal-type tube insertion or removal device includes a body portion, a finger grip portion secured to an end of the body portion, and arm lifts secured to an end of the body portion opposite the finger grip portion. One or more optional stabilizing lifts may likewise be secured to the insertion or removal device in close proximity to the arm lifts. Also methods of using the gastrointestinal-type tube insertion or removal device are described for inserting or removing a skin level gastrointestinal-type tube.
Patent DE-69801043-T2 (DE)
Inventor: KAMINSKY P
IPC: C07C11/02
Filed: 1998-02-26
Granted: 2002-03-14
Abstract: Processes using heterogeneous adsorbents are disclosed for purification of olefins such as are typically produced by thermal cracking of suitable hydrocarbon feedstocks, by passing a stream of olefin having from 2 to about 8 carbon atoms, containing acetylenic impurities having the same or similar carbon content, and optionally saturated hydrocarbon gases, through a particulate bed of predominantly a support material having high surface area on which is dispersed at least one metallic element. Adsorption is carried out in an essentially dihydrogen-free atmosphere within the bed, selective and reversible adsorption and/or complexing of the contained acetylenic contaminants with the adsorbent, and thereby obtain purified effluent which contains less than a predetermined level of the acetylenic impurities. Selective and reversible adsorption and/or complexing of the contained acetylenic impurities with the adsorbent is continued until levels of acetylenic impurities in the effluent stream increase to a predetermined level. Thereafter the resulting bed of adsorbent is regenerated in the presence of a reducing gas containing dihydrogen to effect release of the contained acetylenic impurities from the adsorbent.
Patent DE-69815144-T2 (DE)
Inventor: ERDILE LORNE
IPC: A61K48/00
Filed: 1998-11-20
Granted: 2004-04-01
Abstract: The present invention relates to the use of a solution comprising a non-infectious DNA molecule able to express in a mammal, a physiologically active protein, for the manufacture of a medicament intended to be delivered mainly to the mammalian skin using a needle-free apparatus adapted to this effect. The physiologically active protein can be an antigen that is (i) specific for a microorganism able to induce an infection in a mammal or (ii) tumor-associated; in this case the medicament is for treating or preventing an infection or a tumor disorder. The protein can also be a mammalian protein able to treat a genetic defect e.g., factor XIII or IX; or a cytokine.
Patent DE-69815698-T2 (DE)
Inventor: REMON JEAN PAUL
IPC: A01K51/00
Filed: 1998-12-23
Granted: 2004-04-22
Abstract: A beeswax mimetic substance is described which comprises or consists essentially of a synthetic or semi-synthetic wax, in particular a microcrystalline wax. The wax preferably has a relatively narrow range of mean carbon chain length. An apiculture accessory using the wax and a method of operating beehives using the wax to reduce disease and pests in beehives is described. <IMAGE>
Patent DE-69816759-T2 (DE)
Inventor: JACOBS A
IPC: C11C1/00
Filed: 1998-05-26
Granted: 2004-04-22
Abstract: A novel process for the selective elimination of fatty acid compounds containing carbon-carbon double bonds in trans configuration from a substrate containing cis- and trans-isomers of said fatty acid compounds, by selective adsorption by a microporous zeolite material is disclosed. The pore size and shape of usable zeolite materials enable differentiation between cis- and trans-isomers of unsaturated fatty acid chains. The zeolite materials used have a selectivity ratio alphatrans/cis higher than 1.00; this ratio is defined based on the elution properties of cis and trans double bond containing fatty acid methylesters dissolved in n-hexane during a column chromatography experiment with the zeolite material as the stationary phase and n-hexane as the mobile phase. Besides selective adsorption of trans-unsaturated fatty acid compounds, simultaneous or subsequent total or partial hydrogenation of the double bonds in said compounds can be carried out while using the same or similar zeolite material, containing finely dispersed catalytic active metals. The majority of these catalytic active sites must be inside the pores.
Patent DE-69900645-T2 (DE)
Inventor: CLOP OSCAR
IPC: H04B7/06
Filed: 1999-05-26
Granted: 2002-09-12
Abstract: A base station (1) in a radio communication system is provided with an antenna array 2, 3 for communication with a plurality of mobile stations (4, 5). The transmissions of the base station (1) are optimised by adjusting the phase between the signals transmitted by each antenna (2, 3) so that the product of the propagation channel estimates is maximised. The invention has particular application to CDMA-TDD modes of operation where it has been shown to perform favourably in comparison with known transmit diversity techniques. A further advantage is that it does not require added complexity in the channel estimation at each mobile station (4, 5).  <IMAGE>
Patent DE-69903457-T2 (DE)
Inventor: BAUDRY GILLES
IPC: C21D1/20
Filed: 1999-07-23
Granted: 2003-07-10
Abstract: The invention concerns steel for making a ball bearing part whereof the chemical composition comprises, by weight: 0.6 % </= C </= 1.5 %; 0.4 % </= Mn </= 1.5 %; 0.75 % </= Si </= 2.5 %; 0.2 % </= Cr </= 2 %; 0 % </= Ni </= 0.5 %; 0 % </= Mo </= 0.2 %; 0 % < Al </= 0.05 % ; S </= 0.04 %; the rest being iron and the impurities resulting from the preparation. The composition further satisfies the relationships: Mn </= 0.75 + 0.55 x Si and Mn </= 2.5-0.8 x Si. The enclosure purity of the steel measured by method A of the ASTM E 45 standard further satisfying the following conditions: type A enclosures, fines: index </= 2.5; coarse particles: index 1.5; type B enclosures, fines: index </= 1.5 coarse particles: index </= 0.5; type C enclosures, fines: index = 0; coarse particles: index = 0; type D enclosures, fines: index </= 0.5; coarse particles </= 0.5. The invention also concerns a method for making a ball bearing part and the resulting ball bearing part.
Patent DE-69903967-T2 (DE)
Inventor: JOERESSEN OLAF
IPC: H04B1/713
Filed: 1999-09-21
Granted: 2003-07-17
Abstract: An improved paging procedure for use in a low power radio communications network.A transceiver which pages a device by periodically transmitting a series of messages, comprises a transmitter which transmits a series of messages comprising a message at each frequency in a predetermined series of frequencies, a receiver which receives at, at least a predetermined frequency; and a controller which enables the transmitter and then the receiver in each of a plurality of successive periods and provides each message in said series of messages. The predetermined series of frequencies is an ordered series. A first message in the series of messages transmitted in a period defines directly or indirectly when the receiver is enabled and a second message in the series, a mark code, directly defines the predetermined frequency.
Patent DE-69910607-T2 (DE)
Inventor: HEAP ROLAND GRANT
IPC: F02C7/00
Filed: 1999-11-19
Granted: 2004-07-01
Abstract: An engine is disclosed that incorporates components purely or predominantly rotational components. An engine including a rotor and a stator, in which a combustion chamber is defined in the stator and a fluid receiving chamber is defined in the rotor, in which combustion gas can expand from the combustion chamber into the receiving chamber, whereby momentum is transferred from the combustion gas to the rotor.
Patent DE-69913936-T2 (DE)
Inventor: SASADY NIELS-CHR
IPC: A61B8/12
Filed: 1999-01-05
Granted: 2004-11-18
Abstract: An apparatus for insertion into the human body and which comprises one or more optionally scanning transducers 17,18 and a needle guide 12, which can be operated from the outside. The needle guide 12 is used for collecting tissue samples from the human body. According to the invention the needle guide 12 is separate from the other part of the apparatus which for hygienic reasons is covered by a sterile sheath 14. The needle guide 12 is thus attached to the other part of the catheter via the sheath. In other words the needle guide 12 is arranged outside the sheath 14 in such a manner that the needle need not penetrate the sterile sheath 14, which otherwise would entail that the apparatus should be disinfected after use.
Patent DE-69914145-T2 (DE)
Inventor: KALNES TOM N
IPC: C10G47/18
Filed: 1999-09-06
Granted: 2004-11-25
Abstract: A hydrocarbonaceous feedstock is converted in an integrated hydrotreating and hydrocracking process by combining with a hot hydrocracking zone effluent recycle stream containing hydrogen, and the mixture is passed to a denitrification and desulfurization reaction zone to produce hydrogen sulfide and ammonia to thereby clean up the fresh feedstock. The resulting hot, uncooled effluent from the denitrification and desulfurization zone is hydrogen stripped in a stripping zone maintained at essentially the same pressure as the hydrotreating zone with a hydrogen-rich gaseous stream to produce a vapor stream comprising hydrogen, hydrocarbonaceous compounds boiling at a temperature below the boiling range of the fresh feedstock, hydrogen sulfide and ammonia, and a liquid hydrocarbonaceous stream wherein at least a portion of this liquid stream is then passed to a hydrocracking step to produce the hot hydrocracking effluent recycle stream which is passed back to the hydrotreating zone.
Patent DE-69918952-T2 (DE)
Inventor: DETHIER ALFRED
IPC: B08B9/051
Filed: 1999-05-10
Granted: 2005-08-04
Abstract: The dressing machine for pipeline interiors has a motor-transmission group (9,10) driving brushes supported on a carriage (1 The carriage has motor-transmission groups to drive the wheels (2) for movement of the machine in the pipeline. The machine can centring guide rollers mounted opposite the drive wheels.
Patent DE-69928244-T2 (DE)
Inventor: BEYAERT RUDI
IPC: A61P1/00
Filed: 1999-05-05
Granted: 2006-08-10
Abstract: The present invention relates to novel inhibitors of the Nuclear factor kappa B (NF-kappaB) activating pathway useful in the treatment of NF-kappaB related diseases and/or in the improvement of anti-tumor treatments. These inhibitors interfere early in the TRAF induced signaling pathway and are therefore more specific than IkappaB.
Patent DE-69934595-T2 (DE)
Inventor: NAGAI NOBUO
IPC: A61P7/02
Filed: 1999-09-24
Granted: 2007-10-04
Abstract: The present invention relates to a new means for the treatment of focal ischemic cerebral infarction (ischemic stroke). It has been found that reduction of alpha<SUB>2</SUB>-antiplasmin leads to a significantly smaller focal cerebral infarct size. The invention therefore provides the use of compounds that reduce alpha<SUB>2</SUB>-antiplasmin concentration or activity in vivo, for the preparation of a therapeutical composition for the treatment of focal cerebral ischemic infarction (ischemic stroke).
Patent DE-69936355-T2 (DE)
Inventor: GLENN GREGORY M
IPC: A61P43/00
Filed: 1999-02-25
Granted: 2008-02-21
Abstract: Disclosed is a formulation comprising an antigen and an adjuvant for transcutancous immunization of a subject, wherein the antigen induces an immune response specific for the antigen following application of the formulation to the subject's unperforated skin which is treated to disrupt the stratum corneum.
Patent HU-E035888-T2 (HU)
Title: Modulation of factor 11 expression
Inventor: FREIER SUSAN
IPC: C07H21/00
Filed: 2009-10-15
Abstract: Disclosed herein are antisense compounds and methods for decreasing Factor 11 and treating or preventing thromboembolic complications in an individual in need thereof. Examples of disease conditions that can be ameliorated with the administration of antisense compounds targeted to Factor 11 include thrombosis, embolism, and thromboembolism, such as, deep vein thrombosis, pulmonary embolism, myocardial infarction, and stroke. Antisense compounds targeting Factor 11 can also be used as a prophylactic treatment to prevent individuals at risk for thrombosis and embolism.
Patent HU-E025591-T2 (HU)
Title: Microwave vacuum-drying of organic materials
Inventor: FU JUN
IPC: F26B15/18
Filed: 2010-10-25
Abstract: An apparatus  20  for microwave vacuum-drying organic materials such as foods and bioactives has a plurality of microwave generators  50  actuated so as to cause interference between their respective microwave streams and evenly distribute the microwave energy across the vacuum chamber  34 . The microwave-transparent window  36  in the chamber is arranged so the organic material to be dried is moved across it on a conveyor belt  60  and the microwave energy passing into the chamber  34  immediately encounters the organic materials, thus attenuating the energy and reducing arcing.
Patent HU-E038918-T2 (HU)
Title: Interference limitation for retransmissions
Inventor: LOEHR JOACHIM
IPC: H04W28/04
Filed: 2004-04-01
Abstract: The present invention relates to a method for transmitting data packets from a mobile terminal to a base station using a hybrid automatic repeat request protocol and soft combining of received data. Further, the present invention provides a base station and a mobile terminal both adapted to perform the respective method steps. Moreover, a communication system is provided which comprises at least one base station and at least one mobile terminal. The present invention also provides a computer-readable medium for storing instructions that, when executed on a processor, cause the processor to transmit data packets from a mobile terminal to a base station using a hybrid automatic repeat request protocol and soft combining of received data. In order to restrict the interference caused by retransmissions, the present invention suggests controlling the amount of information in the retransmissions and thus the transmission power required for their transmission by TFCS restriction.
Patent SI-1407044-T2 (SI)
Title: Rna interference mediating small rna molecules
Inventor: TUSCHL THOMAS
IPC: C12N15/113
Filed: 2001-11-29
Abstract: Double-stranded RNA (dsRNA) induces sequence-specific post-transcriptional gene silencing in many organisms by a process known as RNA interference (RNAi). Using a Drosophila in vitro system, we demonstrate that 19-23 nt short RNA fragments are the sequence-specific mediators of RNAi. The short interfering RNAs (siRNAs) are generated by an RNase III-like processing reaction from long dsRNA. Chemically synthesized siRNA duplexes with overhanging 3' ends mediate efficient target RNA cleavage in the lysate, and the cleavage site is located near the center of the region spanned by the guiding siRNA. Furthermore, we provide evidence that the direction of dsRNA processing determines whether sense or antisense target RNA can be cleaved by the produced siRNP complex.
Patent TR-200001462-T2 (TR)
Title: İçeçeklerin tüketimi sırasında tatlandırıcı eklenmesi suretiyle iyileştirilmesi için usul.
Inventor: CAFANO GIUSEPPE
IPC: A23L27/30
Filed: 1997-11-24
Abstract: Tatlar, esanslar, özler,esans yaglari gibi ek maddelarin sakaroz gibi dogal tatlandiricilar ile yapay tatlandiricilarla özellikle de küçük parçalar (15) ya da toz sekline sahip olan bireysel porsiyonlarda bir araya getirilmesi için içeceklerin genelde tüketim aninda tatlandirilmasinin sonucu olarak bunlara tat, rahiya, renk, enerji, vitamin, maden tuzlari kazandirmak için bu ek maddelere (16) karsilik gelen söz, renk, biçime sahip olan çift burgulu ambalajlar ya da paketlere yönelik usul.
Patent TR-200003588-T2 (TR)
Inventor: LINDAHL AKE
IPC: A61K47/10
Filed: 1999-05-12
Abstract: The invention relates to a novel biologically active composition which comprises a biologically active agent to be released therefrom, said biologically active agent being dissolved and/or dispersed in a supersaturated state within a carrier, which carrier is a liquid and/or solid non-crystalline matrix, and where the precipitation of said biologically active agent is substantially, or completely, inhibited therein. Said supersaturated state is obtainable by subjecting one or more carrier starting substance(s) to such chemical operation(s) that a matrix is provided in which the degree of saturation of said biologically active agent is higher than the degree of saturation of said biologically active agent in said carrier starting substance(s), the biologically active agent being added either before said chemical operation(s) or after a predetermined point of time, after which the composition thus prepared is further subjected to said chemical operation(s).
Patent TR-200100839-T2 (TR)
Inventor: HOELDERICH WOLFGANG F
IPC: C10L10/02
Filed: 1999-09-20
Abstract: Glyoxal in an aqueous solution is used in a fuel additive in order to reduce pollutants in the exhaust gases of gasoline and diesel engines. It is sufficient to add glyoxal in aqueous solution to gasoline in the dilution in the ratio of 1:1.000 to 1:20.000 and higher in order to obtain a reduction of unburned hydrocarbons and carbon monoxide in vehicles with catalytic converters at idle and at increased idle of almost 100 %. Esterified aliphats and polyethyleneglycol are added as emulsifiers and solubilizers. Additionally, glyoxal can be used in form of its acetals and hemiacetals with the resultant product being added to the fuel in combustion engines in order to reduce the pollutant emission and carbon particles/deposits.
Patent TR-200101838-T2 (TR)
Title: Lastiklerin üretilmesi için işlem, bu şekilde elde edilen lastikler ve bu lastiklerde kullanılan elastomerik bileşimler
Inventor: NANNI MARCO NAHMIAS
IPC: C08K3/20
Filed: 1999-12-06
Abstract: Tasitlarin tekerlekleri için lastiklerin üretilmesi için islem olup, bu islemde, ham lastik, epoksit gruplarini ihtiva eden bir elastomerik polimeri ve bahsedilen polimer içinde dagilmis hidroksil gruplarini ihtiva eden bir aktif dolgu maddesini içeren en azindan bir çapraz baglanabilir elastomerik malzemeyi içermektedir, bahsedilen elastomerik malzeme esas olarak ek çapraz baglama maddesi olmadan çapraz baglanmistir. Elastomerik malzemenin özelligi, 170 C'da 5 dakikadan çok olmayan isitmadan sonra en azindan %65'e esit olan bir etkili çapraz baglanma derecesidir.
Patent TR-200102844-T2 (TR)
Title: Yüksek hızda silindir baskı ve yapışkan basım işlemi ve düzenaği.
Inventor: MCGUIRE KENNETH STEPHEN
IPC: C09J7/02
Filed: 2000-04-06
Abstract: Mevcut bulus,tercih edilen bir uygulamada asagidaki adimlari içeren bir islem saglamaktadir:(a) bir baslangiç tanjant hizinda dönen bir isitilmis silindire sicak bir eriyik yapiskanin uygulanmasi;(b) yapiskanin daha ince sekilde ezilmesi ve bahsedilen yapiskanin birden fazla bitisik sicak yapiskan silindirleri arasindaki bir seri ölçme bosluklarindan geçirilmesi;(c) yapiskanin baslangiç tanjant hizindan daha yüksek bir tanjant hizinda dönen uygun bir yapiskan uygulama silindirine uygulanmasi;(d) yapiskanin tamamlayici bir desene sahip olan ikinci bir desenli kabartma silindiri ile iç içe geçen bir birinci desenli kabartma silindirine uygulanmasi, kabartma silindirleri isitilir;(e) bir tabaka malzemesi aginin, yapiskan kabartmalar arasinda bir yapiskan deseni olusturacak sekilde ayni anda agin kabartilmasi ve yapiskanin aga uygulanmasi için tanjant hizinda dönen birinci ve ikinci kabartma silindirlerinden geçirilmesi;(f) agin ikinci kabartma silindirinden birinci kabartma  DEVAMI VAR...
Patent TR-200200455-T2 (TR)
Title: İzotretinoin hazırlama işlemi
Inventor: SALMAN MOHAMMAD
IPC: C07D309/32
Filed: 2000-07-24
Abstract: Mevcut bulus, yaygin olarak izotretinoin olarak bilinen A vitamini asidinin 13-cis izomerinin tek bir asamada hazirlanmasi için bir islem ile ilgilidir.
Patent TR-200200610-T2 (TR)
Title: Tek kullanımlık enjeksiyon aleti
Inventor: BRUNEL MARC
IPC: A61M5/32
Filed: 2000-09-15
Abstract: Bulus, bir standart siringa (1) ve adi geçen siringanin (1) enjeksiyon ignesini (2) kullanildiktan sonra koruyan ve birbirlerinin uzantilari ile entegre olacak sekilde adapte edilmis iki arka (9) ve ön (8) gövdeden olusan bir koruyucu kasa (7) ve arka gövdede (9) bulunan ve siringayi (1) kilitleme vasitalari (29,31) takilmis olan bir halka içeren bir kiliftan olusan atilabilir enjeksiyon cihazi ile ilgilidir, adi geçen halka enjeksiyon ignesi (2) kullanildiktan sonra enjeksiyon pozisyonunda sikistirilmis olarak tutulan ve enjeksiyondan sonra birakilan bir yaya (42) yardimiyla birinci enjeksiyon pozisyonu arasinda hareket etmek üzere tasarlanmistir.
Patent DE-602004002681-T2 (DE)
Inventor: DUERR ULRICH
IPC: B23K26/38
Filed: 2004-03-09
Granted: 2007-08-16
Abstract: The device has a laser resonator (4) to generate primary impulsions having duration of microseconds. Modulation units (8) are arranged in between the resonator and a head (24) of the device. The modulation units modulate amplitude of the primary impulsions to supply a set of secondary impulsions. The laser resonator is formed by an active solid atmosphere and optical pumping units.
Patent DE-602004007824-T2 (DE)
Inventor: KROPP MICHAEL A
IPC: C08K9/10
Filed: 2004-10-20
Granted: 2008-04-17
Abstract: A cationically curable composition comprises (a) at least one cationically curable species; (b) at least one cationic photoinitiator; and (c) at least one encapsulated, polymer-bound base.
Patent DE-602004012634-T2 (DE)
Inventor: WONG CHO KEE
IPC: A61F13/00
Filed: 2004-02-26
Granted: 2009-05-14
Abstract: An orthopaedic device is used to correct postural habits of the wearer to reduce the risk of lower back pain and injury, as well as to support the back when the wearer is carrying a heavy load. The device can be incorporated into a belt adapted to be worn about the torso of a user. The pad is typically formed of resilient, yet substantially non-compressive posture-supportive material, having a contoured body-facing surface configured to follow and maintain normal lumbar lordosis of the lower spine. The pad can also be incorporated into a patient-lifting sling to support the back and thighs of a patient, being suspended from a hoist. <IMAGE>